SESE
US • —
$101.40
P/E
40.39
PEG
0.51
FCF Yield
—
Rev Growth YoY
+40.5% YoY
Gross Margin
44.3%
Health Score
6/10
D/E Ratio
0.15
Confidence
LOW
Business Snapshot
The company operates within a sector that is not specified in the provided data, and its specific industry is also not listed. Without this context, it is challenging to precisely define its competitive standing or primary revenue-generating segments. The P/E ratio of 40.39x and Price/Book of 6.07x suggest the market attributes a significant premium to its earnings and assets, which could indicate a high-growth or high-margin business model. Market capitalisation and TTM revenue figures are unavailable from the provided data, making it impossible to classify its size or financial scale. A defining characteristic from the data is its rapid growth trajectory, with revenue up 40.5% year-over-year and earnings up 79.5%, pointing to a company in an expansion phase.
Financial Health
The company displays a mixed financial profile. Its gross margin of 44.3% and net margin of 6.4% suggest reasonable profitability, though no prior year comparisons are available to assess direction...
Risk Assessment
- VALUATION — The P/E ratio of 40.39x trades at a significant premium to the sector average of 22x, making it vulnerable to multiple compression if growth slows.
- EARNINGS QUALITY — The company has beaten analyst estimates in 0 of the last 4 quarters, which raises questions about the reliability of management guidance and earnings quality.
- INSIDER — Insider activity shows 10 sells versus 0 buys in the last 90 days, a net selling pattern that may indicate insiders are reducing their exposure.
- TECHNICALS — RSI, MACD, and moving average data are unavailable for this period; momentum cannot be independently confirmed....
The company displays a mixed financial profile. Its gross margin of 44.3% and net margin of 6.4% suggest reasonable profitability, though no prior year comparisons are available to assess direction. The debt/equity ratio is an asset-light 0.15x, and the current ratio of 1.58x indicates a healthy short-term liquidity position. Return on equity stands at 14.2%, marking efficient capital use. Free cash flow data is not provided, preventing a cash flow health assessment; an investor cannot confirm whether the company is self-funding growth. Overall, the company has a clean balance sheet with modest debt, but the lack of cash flow data creates uncertainty about its ability to sustain reinvestment without external financing.
- VALUATION — The P/E ratio of 40.39x trades at a significant premium to the sector average of 22x, making it vulnerable to multiple compression if growth slows. - EARNINGS QUALITY — The company has beaten analyst estimates in 0 of the last 4 quarters, which raises questions about the reliability of management guidance and earnings quality. - INSIDER — Insider activity shows 10 sells versus 0 buys in the last 90 days, a net selling pattern that may indicate insiders are reducing their exposure. - TECHNICALS — RSI, MACD, and moving average data are unavailable for this period; momentum cannot be independently confirmed.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives